Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine
LP.8.1 variant adapted COVID-19 vaccine COMIRNATY is now authorized in Canada for individuals 6 months of age and older. It is expected to be available in Canada in the coming weeks. This season's ...
MONTREAL, CANADA – Pfizer Canada’s pharmaceutical division is among Canada’s best companies to work for, says a closely watched annual survey by Report on Business Magazine. The magazine, published by ...
With the approval of ABRYSVO® for adults aged 18+, there is now a way to help protect against RSV in a population that previously did not have vaccination options. KIRKLAND, QC, Oct. 21, 2025 /CNW/ - ...
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
TORONTO, ON — Canadian health officials said Wednesday they have become the first to approve Pfizer’s COVID-19 vaccine for ages as young as 12. Dr. Supriya Sharma, chief medical adviser at Health ...
(RTTNews) - Pfizer Canada ULC and BioNTech SE (BNTX) announced that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY COVID-19 vaccine for individuals aged 6 months and older. The ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Canadians looking to get a COVID-19 vaccine at local pharmacies may run into some trouble. Pfizer Canada says it has placed temporary limits on orders of one of its COVID shots at community pharmacies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results